100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
1732-10-1Dimethyl Azelate
● Auf Lager
| Katalog-Nr.:: | VL1420009 |
|---|---|
| CAS-Nr.:: | 1732-10-1 |
| Summenformel:: | C11H20O4 |
| Molare Masse:: | 216.27 g/mol |
Zusätzliche Informationen zu CAS 1732-10-1
Parent drug
Azelaic AcidIUPAC-Name
dimethyl nonanedioatePharmacopeial Synonyms
N/ASynonyme
N/ASMILES
O=C(OC)CCCCCCCC(OC)=OInChI
InChI=1S/C11H20O4/c1-14-10(12)8-6-4-3-5-7-9-11(13)15-2/h3-9H2,1-2H3Beschreibung
Dimethyl Azelate (CAS 1732-10-1) is a common process-related impurity encountered in esterification and transesterification routes. As the dimethyl ester of azelaic acid, it exhibits moderate volatility and lipophilicity, which influences its partitioning during distillation and solvent extraction. Analytical identification relies on GC-MS and LC-MS complemented by 1H and 13C NMR for structural confirmation, with quantitation at trace and ppm levels using validated methods. Left uncontrolled it can affect product purity, stability, and downstream catalytic steps. Control strategies include optimized reaction stoichiometry, targeted downstream purification such as fractional distillation, adsorption or liquid liquid extraction, and routine monitoring against established specification limits.References
Nazzaro-Porro, Marcella. “Azelaic Acid.†Journal of the American Academy of Dermatology, vol. 17, no. 6, 1 Dec. 1987, pp. 1033–1041, www.sciencedirect.com/science/article/abs/pii/S0190962287702941, 10.1016/S0190-9622(87)70294-1. Accessed 28 Jan. 2022.Angebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Azelaic Acid impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
